Sarepta Therapeutics
SRPT
#1423
Rank
$12.15 B
Marketcap
$129.46
Share price
-0.59%
Change (1 day)
-1.28%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Revenue for Sarepta Therapeutics (SRPT)

Revenue in 2023 (TTM): $1.24 B

According to Sarepta Therapeutics 's latest financial reports the company's current revenue (TTM) is $1.24 B. In 2022 the company made a revenue of $0.93 B an increase over the years 2021 revenue that were of $0.70 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sarepta Therapeutics from 2001 to 2023

Annual revenue

Year Revenue Change
2023 (TTM)$1.24 B33.26%
2022$0.93 B32.93%
2021$0.70 B29.96%
2020$0.54 B41.82%
2019$0.38 B26.51%
2018$0.30 B94.74%
2017$0.15 B2751.58%
2016$5.42 M332.64%
2015$1.25 M-87.16%
2014$9.75 M-31.38%
2013$14.21 M-61.91%
2012$37.32 M-20.56%
2011$46.99 M59.72%
2010$29.42 M67.27%
2009$17.58 M-17.26%
2008$21.25 M93.52%
2007$10.98 M9428.23%
2006$0.11 M-97.59%
2005$4.78 M1011.31%
2004$0.43 M-55.62%
2003$0.96 M15.9%
2002$0.83 M18.51%
2001$0.7 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$27.11 B 2,080.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.93 B-24.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.69 B-44.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.82 B 47.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.30 B-75.45%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.33 B-73.34%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.56 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA